| ¿µ¹® | nicotine | ÇÑ±Û | ´ÏÄÚÆ¾ |
|---|---|---|---|
| ¼³¸í | ºÐÀÚ½ÄÀº C10H14N2 ºÐÀÚ·®Àº 162.23ÀÌ´Ù. °¡Áö°úÀÇ ½Ä¹°ÀÎ ´ã¹è(Nicotiana tabacum)¿¡ µé¾îÀÖ´Â ´ë´ÜÈ÷ À¯µ¶ÇÑ ¹«»öÀÇ °¡¿ë¼º ¾×ü»ó ¾ËÄ®·ÎÀ̵å, ¹«»öÀÇ Èֹ߼º ¾×ü·Î, ºûÀ̳ª °ø±â¿Í Á¢ÇÏ¸é »êÈÇÏ¿© °¥»öÀ» ¶ì°í, ¾ËÄÚ¿ÃÀ̳ª ¿¡Å׸£ µûÀ§¿¡ Àß ³ì´Â´Ù. ´ã¹è¿¡¼ ¾ò¾îÁö°Å³ª ÇÕ¼ºÀûÀ¸·Î Á¦Á¶µÈ´Ù. µ¶¼ºÀÌ ÀÖ¾î¼ ÀûÀº ¾çÀº ½Å°æÁ¶Á÷À» ÈïºÐ½ÃÄÑ Á¤½Å Ȱµ¿À» ¿Õ¼ºÇÏ°Ô ÇÏÁö¸¸, ¸¹Àº ¾çÀº ½Å°æÁ¶Á÷À» ¸¶ºñ½ÃŲ´Ù. |
||
| ¿µ¹® | inhalation | ÇÑ±Û | ÈíÀÔ(¹ý) |
|---|---|---|---|
| ¼³¸í | 1. ÈíÀÔ. °ø±â³ª ¾î¶² ¹°ÁúÀ» Æó¼ÓÀ¸·Î »¡¾ÆµéÀÌ´Â °Í. 2. ¾à ¶Ç´Â ¾àÀÇ ¿ë¾×À» ºÐ¹«±â¸¦ ÀÌ¿ëÇϰųª ¿¬¹«ÁúÀÇ ÇüÅ·ΠÄÚ³ª ÀÔÀÇ È£ÈíÅë·Î¸¦ ÅëÇØ¼ Åõ¿©ÇÏ´Â ¹æ¹ý. |
||
| ¿µ¹® | oral administration | ÇÑ±Û | °æ±¸º¹¿ë |
|---|---|---|---|
| ¼³¸í | ¾àÀ» Åõ¿©ÇÏ´Â ¹æ¹ý¿¡´Â ¿©·¯ °¡Áö°¡ ÀÖ´Ù. Å©°Ô ³ª´©¾î º¸¸é, ÀÔÀ» °ÅÃÄ À§Ã¢Àڰ踦 ÅëÇØ ³Ö´Â ¹æ¹ý°ú À§Ã¢Àڰ踦 ÅëÇÏÁö ¾Ê°í ¹Ù·Î Ç÷¾×À¸·Î ³Ö´Â ¹æ¹ýÀÌ ÀÖ´Ù. À§Ã¢Àڰ踦 ÅëÇÏÁö ¾Ê´Â ¹æ¹ýÀ¸·Î °¡Àå ÈçÇÑ ¹æ¹ýÀº Áֻ縦 ÀÌ¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù. ÇÏÁö¸¸, À̿ܿ¡ Ç×¹®À» ÅëÇØ ³Ö´Â Á¾à½Ä¹æ¹ý°ú Çô¹Ø¿¡ ³Ö´Â Çô¹ØÅõ¿©¹ýµµ ÀÖ´Ù. ±×·¯³ª ´ëºÎºÐÀÇ ¾àÁ¦´Â °æ±¸º¹¿ëÀ» ÇÏ°Ô µÈ´Ù. °æ±¸º¹¿ë¿¡ ´ëÇÑ ¾àÀÚ´Â p.o.(per oral)·Î Ç¥±âÇÑ´Ù. °æ±¸º¹¿ëÁ¦ÀÇ ´ÜÁ¡Àº º¹¿ëÇÑ ¾àÁ¦°¡ À§Ã¢ÀÚ°ü°è¸¦ °ÅÄ¡¸é¼ »ç¶÷¸¶´Ù °¢±â ´Ù¸¥ Èí¼öÁ¤µµ¿Í ´ë»çÁ¤µµ¸¦ °ÅÄ¡°Ô µÇ¹Ç·Î ÀÏÁ¤ÇÑ ³óµµÀ¯Áö°¡ ¾î·Æ´Ù´Âµ¥ ÀÖ´Ù. ¶ÇÇÑ °æ±¸º¹¿ëÁ¦ÀÇ ¸ð¾çÀÌ Ä¸½¶ÇüÀÎÁö, ȤÀº °¡·çÇüÀÎÁö¿¡ µû¶ó¼µµ °°Àº ¾àÀÌÁö¸¸, ¼·Î ´Ù¸¥ È¿°ú¸¦ ³ªÅ¸³¾ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | oral cavity | ÇÑ±Û | ±¸° |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ¹ú¿©¼ ÀÔ¼Ó¿¡¼ º¼ ¼ö ÀÖ´Â °ø°£À¸·Î ÀÔõÀå, Æíµµ, ¸ñÁ¥À» º¼ ¼ö ÀÖ´Ù. ![]() |
||
| ¿µ¹® | oral cavity | ÇÑ±Û | ÀÔ¾È |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ¹ú¿©¼ ÀÔ¼Ó¿¡¼ º¼ ¼ö ÀÖ´Â °ø°£À¸·Î ÀÔõÀå, Æíµµ, ¸ñÁ¥À» º¼ ¼ö ÀÖ´Ù. |
||
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
|---|---|
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
| NSN | nephrotoxic serum nephritis; nicotine-stimulated neurophysin |
| NT | nasotracheal; neotetrazolium; neurotensin; neurotrophic; neutralization test; nicotine tartrate; non... |
| T/N | tar and nicotine |
| MIC | Methacholine inhalation challenge |
|---|---|
| DI | deep inhalation |
| N | 1-nicotine |
| 6-HDNO | 6-Hydroxy-D-nicotine oxidase |
| FTND | Fagerstrom Test for Nicotine Dependence |
naso-oral
| nicotine | <drug> A plant alkaloid from tobacco, blocks transmission at nicotinic synapses. (18 Nov 1997) |
|---|---|
| nicotine dehydrogenase | <enzyme> Mo-pterin-fe-s cluster- and fad-dependent enzyme composed of 3 unequal polypeptides; catalyses the conversion of nicotine, acceptor, and water to (s)-6-hydroxynicotine and reduced acceptor Registry number: EC 1.5.99.4 (26 Jun 1999) |
| nicotine oxidase | <enzyme> Cytochrome p-450 enzyme Registry number: EC 1.5.3.- (26 Jun 1999) |
| nicotine stomatitis | Heat stimulated lesions, usually on the palate, that begin with erythema and progress to multiple white papules with a red dot in the centre. The red dot represents a dilated, inflamed salivary duct orifice. (05 Mar 2000) |
| administration, inhalation | The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. (12 Dec 1998) |
| anaesthesia, inhalation | Anaesthesia caused by the breathing of anaesthetic gases or vapors or by insufflating anaesthetic gases or vapors into the respiratory tract. (12 Dec 1998) |
| anaesthetics, inhalation | Gases or volatile liquids that vary in the rate at which they induce anaesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anaesthetics have advantages over intravenous agents in that the depth of anaesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (12 Dec 1998) |
| burns, inhalation | Burns of the respiratory tract caused by heat or inhaled chemicals. (12 Dec 1998) |
| smoke inhalation injury | Pulmonary injury following the breathing in of toxic smoke from burning materials such as plastics, synthetics, building materials, etc. This injury is the most frequent cause of death in burn patients. (12 Dec 1998) |
| solvent inhalation | Inhalation of volatile organic solvents used in glue, nail polish remover, lacquer thinners, cleaning fluid, lighter fluid, and gasoline, for the purpose of self-intoxication. See: glue-sniffing. (05 Mar 2000) |
| inhalation | <physiology> The drawing of air or other substances into the lungs. Origin: L. Inhalatio (18 Nov 1997) |
| inhalation anaesthesia | General anaesthesia resulting from breathing of anaesthetic gases or vapors. (05 Mar 2000) |
| inhalation anaesthetic | A gas or a liquid with sufficient vapor pressure to produce general anaesthesia when breathed. (05 Mar 2000) |
| inhalation analgesia | Analgesia produced by inhalation of a central nervous system depressant gas (especially nitrous oxide) or vapor. (05 Mar 2000) |
| inhalation exposure | The exposure to potentially harmful chemical, physical, or biological agents by inhaling them. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|